Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | Peroxidase homolog | 0.0182 | 0.5523 | 0.5 |
Echinococcus granulosus | Pyruvate dehydrogenase lipoamide kinase | 0.0257 | 1 | 1 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.0257 | 1 | 1 |
Onchocerca volvulus | Peroxidase homolog | 0.0182 | 0.5523 | 0.5 |
Onchocerca volvulus | 0.0182 | 0.5523 | 0.5 | |
Trypanosoma cruzi | developmentally regulated phosphoprotein, putative | 0.0257 | 1 | 1 |
Onchocerca volvulus | 0.0182 | 0.5523 | 0.5 | |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0243 | 0.9145 | 0.809 |
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.0104 | 0.0855 | 1 |
Onchocerca volvulus | Peroxidasin homolog | 0.0182 | 0.5523 | 0.5 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0257 | 1 | 1 |
Onchocerca volvulus | 0.0182 | 0.5523 | 0.5 | |
Trypanosoma brucei | developmentally regulated phosphoprotein | 0.0257 | 1 | 1 |
Leishmania major | developmentally regulated phosphoprotein-like protein | 0.0257 | 1 | 1 |
Onchocerca volvulus | Dual oxidase homolog | 0.0182 | 0.5523 | 0.5 |
Onchocerca volvulus | Chorion peroxidase homolog | 0.0182 | 0.5523 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0257 | 1 | 1 |
Onchocerca volvulus | Peroxidasin homolog | 0.0182 | 0.5523 | 0.5 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.0257 | 1 | 1 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0243 | 0.9145 | 0.809 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
pA2 (functional) | = 6.31 | In vitro antagonistic activity against kinin-induced rabbit jugular vein contraction. | ChEMBL. | 8642569 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.